hypertonic bicarbonate
Drug8.4% sodium bicarbonate inhaled
Other names: sodium bicarbonate
NCT Number: NCT03391414
This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is possible to decrease the acidity of the airways by inhaling sodium bicarbonate through nebulizer treatments.
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Phase 1
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is possible to decrease the acidity of the airways by inhaling sodium bicarbonate through nebulizer treatments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8.4% sodium bicarbonate inhaled
Other names: sodium bicarbonate
7% sodium chloride inhaled
Other names: hyper-sal
Time frame: two time points (baseline and four (4) hours)
Change in pH after inhalation of two doses on one day
Time frame: two time points (Baseline and four (4) hours)
Change in sputum wet-to-dry ratio ratio after inhalation of two doses on one day
Time frame: two time points (baseline and four (4) hours)
FEV1 before and after inhalation of two doses on one day
Joseph Pilewski
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02715921
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Irvine, California, United States
View Trial DetailsNCT04798014
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Indianapolis, Indiana, United States
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT05453578
Bacterial Disease Carrier, Bacterial Infections
Tucson, Arizona, United States
View Trial Details